Milestone Reached on Path to New Form of Male Contraception (2/3) (IMAGE)
Caption
A 3-D model of the contraceptive drug target TSSK2 and protein samples [red and blue bands] of the purified, full-length human enzyme that was genetically engineered in insect cells.
Credit
UVA Health System
Usage Restrictions
May be used by reporters and webmasters to accompany news coverage of John Herr's development of a new male contraceptive.
License
Licensed content